← Open Payments lookup

MICHAEL MATHISEN: Open Payments

NPI 1114487881 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,490 in 77 payments from 13 companies in 2025. Trend: 2023 $2,432 · 2024 $1,996 · 2025 $2,490

Food & beverage: $2,490
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$647
E.R. Squibb & Sons, L.L.C.12$363
Otsuka America Pharmaceutical, Inc.11$344
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$257
ABBVIE INC.8$236
Janssen Pharmaceuticals, Inc5$194
Alkermes, Inc.6$175
Teva Pharmaceuticals USA, Inc.4$102
Almatica Pharma LLC3$52
Vanda Pharmaceuticals Inc.1$39

Products named: INGREZZA, COBENFY, CAPLYTA, VRAYLAR, REXULTI, ARISTADA, SPRAVATO, ABILIFY MAINTENA.

Industry payments across NV — which companies pay providers there.